Cavid Baba

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Particulate Matter

Community Dwelling

Top Venues

Acta neurologica Belgica

Journal of neurology

Brain and behavior

Neurology and clinical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Zuhal Abasıyanık, Turhan Kahraman, Cavid Baba, Özge Sağıcı, Özge Ertekin, Serkan Özakbaş, null null
Discriminative ability of the original and short form of the Activities-specific Balance Confidence scale and its individual items for falls in people with multiple sclerosis. Acta neurologica Belgica (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology 271 (7) (2024)
Cavid Baba, Zuhal Abasiyanik, Yasemin Simsek, Asiye Tuba Ozdogar, Ozge Sagici, Serkan Ozakbas
Predictors of relapse severity in multiple sclerosis. Acta neurologica Belgica (2024)
Zuhal Abasıyanık, Turhan Kahraman, Cavid Baba, Özge Sağıcı, Özge Ertekin, Serkan Özakbaş, null null
Discriminative ability of the original and short form of the Activities-specific Balance Confidence scale and its individual items for falls in people with multiple sclerosis. Acta neurologica Belgica 124 (3) (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology 271 (7) (2024)
Zuhal Abasıyanık, Turhan Kahraman, Cavid Baba, Özge Sağıcı, Özge Ertekin, Serkan Özakbaş, null null
Discriminative ability of the original and short form of the Activities-specific Balance Confidence scale and its individual items for falls in people with multiple sclerosis. Acta neurologica Belgica 124 (3) (2024)
Cavid Baba, Zuhal Abasiyanik, Yasemin Simsek, Asiye Tuba Ozdogar, Ozge Sagici, Serkan Ozakbas
Predictors of relapse severity in multiple sclerosis. Acta neurologica Belgica 124 (2) (2024)
Zuhal Abasıyanık, Turhan Kahraman, Cavid Baba, Özge Sağıcı, Özge Ertekin, Serkan Özakbaş, null null
Discriminative ability of the original and short form of the Activities-specific Balance Confidence scale and its individual items for falls in people with multiple sclerosis. Acta neurologica Belgica 124 (3) (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology 271 (7) (2024)
Cavid Baba, Zuhal Abasiyanik, Yasemin Simsek, Asiye Tuba Ozdogar, Ozge Sagici, Serkan Ozakbas
Predictors of relapse severity in multiple sclerosis. Acta neurologica Belgica 124 (2) (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology 271 (7) (2024)
Turhan Kahraman, Hasretgul Temiz, Zuhal Abasıyanık, Cavid Baba, Serkan Özakbaş
Dual-task difficulties as a risk factor for unemployment in people with multiple sclerosis. Brain and behavior (2023)
Serkan Ozakbas, Bilge Piri Cinar, Cavid Baba, Gorkem Kosehasanogullari, Multiple Sclerosis Research Group
Self-injectable DMTs in relapsing MS: NEDA assessment at 10 years in a real-world cohort. Acta neurologica Scandinavica 145 (5) (2022)
Cavid Baba, Pinar Yigit, Seda Dastan, Pelin Hancer, Ozge Sagici, Serkan Ozakbas, Zuhal Abasiyanik
Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID-19 pandemic. Neurology and clinical neuroscience 10 (1) (2021)